Immediate Impact

44 standout
Sub-graph 1 of 22

Citing Papers

PI3K/Akt/mTOR Signaling Pathway as a Target for Colorectal Cancer Treatment
2024 Standout
NF-κB in biology and targeted therapy: new insights and translational implications
2024 Standout
2 intermediate papers

Works of J. Sundberg being referenced

Lenalidomide, Bendamustine, and Rituximab As First-Line Therapy For Patients >65 Years With Mantle Cell Lymphoma: Preliminary Results From The Nordic Lymphoma Group MCL4 (LENA-BERIT) Phase I-II Trial
2013
A randomized phase III trial on maintenance treatment with bevacizumab alone or in combination with erlotinib after chemotherapy and bevacizumab in metastatic colorectal cancer: the Nordic ACT Trial
2013

Author Peers

Author Last Decade Papers Cites
J. Sundberg 62 179 89 85 18 309
Philip Bennett 73 51 86 48 20 329
Alaa Muslimani 69 79 98 71 27 262
James H. Muchmore 64 256 118 31 24 363
Miriam Quitt 48 65 45 55 30 288
Nadia Montani 73 45 37 27 20 332
R. Grace 103 68 52 125 17 347
Jwa Hoon Kim 78 174 106 70 28 320
Óscar Toldos 67 44 50 26 20 334
N J Carty 134 108 59 128 24 371
Zhaojun Lu 70 27 42 33 25 290

All Works

Loading papers...

Rankless by CCL
2026